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Abstract
Background: Breast cancer is the most prevalent cancer in women worldwide and metastatic breast cancer has very poor
prognosis. Inflammation has been implicated in migration and metastasis of breast cancer, although the exact molecular
mechanism remains elusive.
Principal Findings: We show that the pro-inflammatory endotoxin Lipopolysaccharide (LPS) upregulates the expression of
Metadherin (MTDH), a recently identified oncogene, in a number of breast cancer lines. Stable knockdown of MTDH by
shRNA in human breast MDA-MB-231 cells abolishes LPS-induced cell migration and invasion as determined by several in
vitro assays. In addition, knockdown of MTDH diminishes Nuclear Factor-kappa B (NF-kB) activation by LPS and inhibited
LPS-induced IL-8 and MMP-9 production.
Conclusions: These results strongly suggest that MTDH is a pivotal molecule in inflammation-mediated tumor metastasis.
Since NF-kB, IL-8 and MMP-9 play roles in LPS-induced invasion or metastasis, the mechanism of MTDH-promoted invasion
and metastasis may be through the activation of NF-kB, IL-8 and MMP-9, also suggesting a role of MTDH in regulating both
inflammatory responses and inflammation-associated tumor invasion. These findings indicate that MTDH is involved in
inflammation-induced tumor progression, and support that MTDH targeting therapy may hold promising prospects in
treating breast cancer.
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Introduction
Breast cancer is the most prevalent cancer in women worldwide
and metastatic breast cancer has very poor prognosis. Although
breast cancer incidence rate has been decreasing in the past
decades due to the early detection, breast cancer remained to be of
the top incidence rate and it has the second highest cancer
mortality in women [1]. Breast cancer is a heterogeneous disease
and is stratified by race, stage, grade, and estrogen (ER)/
progesterone (PR) receptor status. Typically, there are two broad
categories of genetic changes in the process of tumorigenesis:
tumor suppressor genes and oncogenes. Tumor suppressor genes,
including BRCA2, inhibit cell division, survival, or other
properties of cells. They are often disabled in cancer cells therefore
to promote the malignant changes. Oncogenes promote malig-
nancy by expressing at inappropriately high levels, or being altered
to have novel properties [2]. Metadherin (MTDH) is a recently
identified oncogene [3]. Here we report the role of MTDH in
promoting invasion and metastasis in breast cancers.
MTDH, (also known as astrocyte elevated gene-1, AEG-1 and
Lyric), is a newly cloned gene, which has aberrantly higher copy
numbers at 8q22 in breast cancer patients [4]. MTDH is a 64 kDa
single transmembrane protein and located in the cytoplasm,
endoplasmic reticulum, perinuclear regions, and nucleolus [5,6].
The expression of MTDH has been detected in melanoma,
glioma, neuroblastoma, and carcinomas of breast, prostate, liver,
kidney, colorectum and esophagus [7,8,9]. The expression levels of
MTDH is positively correlated with tumorigenesis, migration,
invasion, angiogenesis, EMT (epithelial mesenchymal transition)
and chemoresistance in various cancer types [3,10,11,12,13].
Current studies have revealed that MTDH could be a
prognostic factor in breast cancer: its high expression is associated
with poor survival [14]. Statistical analysis showed a significant
correlation of MTDH expression with the clinical staging of the
patients, tumor classification, node classification, and metastasis
classification. Previous studies from our group have also shown a
significant correlation between MTDH expression with patients’
age, ER status and p53 status that are also poor prognostic
features, further supporting the notion that MTDH expression is
correlated with poor prognosis and high morbidity in breast
cancer patients [15]. Previously, MTDH has been shown to
induce the lung metastasis with a ‘‘lung-homing domain’’ selected
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phage cDNA library and has been related to tumor angiogenesis
with the expression of vascular endothelial growth factor (VEGF)
and microvessel density (MVD) [16,17]. Our group also
demonstrated the role of MTDH in promoting metastatic seeding
and enhancing chemoresistance [4]. Recently we found that
MTDH enhanced EMT which drove the aggressive behavior of
the breast cancer and identified novel SNPs of MTDH that are
correlated to breast cancer susceptibility [12,18]. Recently the
MTDH/AEG-1-based DNA vaccine was shown to increase
chemosensitivity to doxorubicin in inhibiting breast cancer
metastasis to the lung[19]. These studies suggested MTDH as a
potential candidate of target therapy for cancer, especially for
enhancing the efficacy of chemotherapy and reducing metastasis.
About 150 years ago, Virchow first discovered the relationship
between chronic inflammation and carcinogenesis [20], which
attracted extensive studies. The last decade witnessed increased
interest and extensive studies on tumor microenvironment that
contributes to neoplastic process, cell proliferation and migration
[21]. Among those factors such as the recruitment of microenvi-
ronmental cells and the cytokines those cell secreted into the tumor
microenvironment, the activation of TLR4 was considered as a
two edged sword, which has both the anti-tumor and pro-tumor
functions [22]. Lipopolysaccharide (LPS), the major component of
the outer membrane of Gram-negative bacteria, also the ligand of
TLR4, could up-regulate the expression of MTDH in human
promonocytic cell line which takes part in the regulation of the
TLR4 signaling pathway, including the activation of Nuclear
Factor-kappa B (NF-kB). These observations suggest that MTDH
might play an important role in the regulation of innate immunity
[11]. NF-kB can promote inflammation-associated tumerigenesis
and is related to the MTDH-associated tumor progression and
metastasis in cervical cancers [23,24]. It remains elusive whether
MTDH plays a causative role in LPS-induced tumor progression
and metastasis. Here we determined the function of MTDH in
promoting tumor progression in response to LPS and investigated
how LPS regulated MTDH expression in breast cancer cells.
Results
LPS induced the upregulation of MTDH in the TLR4-
positive breast cancer cells
First, we examined which breast cancer cell lines were TLR4
positive. We evaluated the expression of TLR4 at mRNA level by
Real Time RT-PCR. TLR4 expression was detected in three
breast cell lines including MDA-MB-231, MCF-7 and MDA-MB-
468. TLR4 was undetectable in the cell line T47D, which was
used as negative control in our study. The mRNA level of TLR4
was higher in MDA-MB-231 cells than MCF-7 and MDA-MB-
468 (Figure 1A). Although the differences of TLR4 protein levels
were not so obvious perhaps because of translation control, the
expression levels of TLR4 protein in these four cells still showed
similar pattern as determined by the Western-blot assays
(Figure 1B). Next, we examined the effects of LPS on the
expression of MTDH in these cells. As shown in Figure 1C, the
expression of MTDH protein changed in a concentration-
dependent manner, the peak appeared in the three TLR4 positive
cells (MDA-MB-231, MCF-7, and MDA-MB-468) when cells were
stimulated with LPS at the concentration of 100 ng/ml. In the
TLR4 negative T47D cell line, no significant change of MTDH
expression was observed when the cells were treated with LPS.
The basal total p65 expression was not significantly different
among the four types of cell lines as shown in Figure 1B, suggesting
that the different reactions to the LPS stimulation were not due to
the lack of basal NF-kB expression. Since MTDH expression level
peaked at a concentration of LPS 100 ng/ml, in the following
experiments we selected MDA-MB-231 cells as the representative
TLR4 positive cells and T47D as TLR4 negative cells treated with
100 ng/ml LPS. We evaluated MTDH expression at mRNA and
protein levels at different time points in MDA-MB-231 cells which
show clear induction of MTDH by LPS (Figure 2). The results
suggested that LPS upregulated the MTDH expression in time-
dependent and concentration-dependent manners in TLR4
positive breast cancer cells. There were reports that MTDH was
activated over a long period through PI3K/AKT while it was
activated within 30 min through the NF-kB signal pathway [11].
LPS induced up-regulation of MTDH and increased the
migration ability of MDA-MB-231 cells
Since MTDH is considered to be involved in tumor migration
and invasion [13], and the LPS induced inflammation response
upregulates the MTDH expression in breast cancer cells, we
carried out the in vitro scratch assays to investigate whether
elevated MTDH levels are responsible for the enhanced tumor
migration. We knocked down the MTDH expression by shRNA
against MTDH. The decrease of MTDH was confirmed at both
protein and mRNA levels (Figure 3A). Knockdown of MTDH in
MDA-MB-231 cell significantly reduced the migration ability. As
shown in Figure 3B, C, MTDH knockdown resulted in a
significant decrease in the cell motility after 24 hours of migration
with cell migrated (5.5660.59)610
21 mm (all the starting wound
distance was approximately 1 mm) in prp-control cells while in
prp-MTDH cells the distance was only (4.0660.67)610
21 mm.
LPS treatment did not change the migration in TLR4 negative
T47D cells, however, clearly increased migration in TLR4 positive
MDA-MB-231 cells. In the prp-control-231 cells, LPS pretreated
cells migrated (7.0260.87)610
21 mm compared with (5.5660.59)
610
21 mm in un-pretreated cells, the difference was significant
(p=0.02). However, this kind of change was not observed in the
MTDH knockdown (prp-MTDH-231) cells when the data showed
cell motilities were (4.1860.68)610
21 mm and (4.0660.67)6
10
21 mm in LPS pretreated and un-pretreated cells (p=0.39).
This change demonstrated that elevated MTDH expression was
required for LPS-induced breast cancer cell migration.
LPS increased the invasive ability of MDA-MB-231 cells
Since MTDH mediates LPS-induced cell migration, we went on
to examine the effect of LPS-induced MTDH on invasion in MDA-
MB-231 cells. First we examined whether LPS affected the
proliferation ability of the MDA-MB-231 cells. MDA-MB-231 cells
were cultured with various concentrations of LPS (0.01, 0.1, 1.0,
10 ug/ml)for24,48,72,96 hoursand theproliferation ofcellswere
measured. LPS did not have obvious effect on the proliferation of
MDA-MB-231 cells (data not shown). The invasion ability of the
cells was significantly increased upon LPS treatment (100 ng/ml)
for 18 hours in TLR4 positive cells. In TLR4 negative T47D cells,
there was no change in invasion ability. Interestingly, the effect of
LPS on promoting invasion was completely abolished by MTDH
knockdown (Figure 4). These results strongly suggest that LPS
increased the invasive ability of MDA-MB-231 cells through the up-
regulation of MTDH expression.
LPS induced MTDH expression regulated the TLR4
signaling pathways
The TLR4 signaling pathway includes MyD88 (myeloid
differentiation primary response gene 88)-dependent and
MyD88-independent pathways [25]. It has been reported that
MTDH Mediates LPS-Induced Invasion
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MyD88, whereas late-phase NF-kB activation was dependent on
TRIF (TIR domain-containing adaptor inducing IFN-b,mediating
MyD88-independent signaling), and both phases of NF-kB
activation were required for cytokine production [26]. We
evaluated the MYD88, IRAK4 (IL-1 receptor-associated kinase
4) expressions which were in the MYD88-dependent pathway and
TRIF which was involved in MYD88-independent pathway by
Western-blot assays. The expression levels of TLR4, IRAK4,
TRIF and P-p65 were decreased in MTDH knockdown cells
(Figure 5A). As shown in Figure 5A, all the protein mentioned
above in the TLR4 signaling pathway were upregulated when
stimulated by LPS, and in the MTDH knockdown cells the TLR4
and TRIF were slightly upregulated meanwhile MyD88, IRAK4
expression changes were not obvious. Those results implied that
LPS activated MTDH in the TLR4 signaling pathway and the
depletion of MTDH turned out to further impede this pathway.
The NF-kB family (also known as the Rel/NF-kB family) of
transcription factors consists of five members: p50, p52, RelA (also
known as p65), RelB and c-Rel. With the activation of NF-kB, the
p65 was phosphorylated; the p50-p65 NF-kB translocated into the
nucleus, which in turn bound to the specific sequence and
augmented related downstream gene transcription. LPS treatment
in prp-control cells increased the P-p65 level (Figure 5A),
suggesting that NF-kB was activated by LPS-induced upregulation
of MTDH, which is consistent with the previous study that
MTDH activates the NF-kB pathway [27]. In the MTDH
knockdown cells, the P-p65 was barely detectable with or without
the stimulation of LPS, providing evidence that MTDH mediates
the activation of NF-kB by LPS.
Cytokines production changes detected with the
stimulation of LPS
IL-8 and MMP-9 are the NF-kB downstream genes and their
expressions were examined by Real Time RT-PCR. When
MTDH was knocked down, the expressions of both IL-8 and
MMP-9 decreased to 0.16-fold and 0.38-fold of those expressed in
prp-control cells (Figure 5B, C). With the stimulation of LPS, both
IL-8 and MMP-9 expression in prp-control cells increased
Figure 1. LPS upregulates MTDH expression in TLR4 positive breast cancer cell lines. (A, B) The mRNA levels (A) and the protein
expression levels (B) of TLR4 were measured by Real Time RT-PCR and western blots respectively. Total RNA and protein were extracted from the
T47D, MDA-MB-231, MCF-7 and MDA-MB-468 cell lines. (C) MTDH expressions at protein level in different cell lines were analyzed by western blots
with the stimulation of various concentrations of LPS for 1 hour. b-actin was selected to be the endogenous control.
doi:10.1371/journal.pone.0029363.g001
Figure 2. LPS upregulates MTDH expression in a time-
dependent manner. (A, B) MDA-MB-231 cells were cultured with
LPS (100 ng/ml) for various times and the expression of MTDH was
examined at both mRNA (A) and protein (B) levels., b-actin was selected
to be the endogenous control.
doi:10.1371/journal.pone.0029363.g002
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treatment increased the expression of IL-8 by ,44-fold and
MMP-9 by ,3-fold in prp-control cells; in prp-MTDH cells, the
induction of IL-8 and MMP-9 by LPS was ,4-fold and ,2-fold,
respectively. These results indicated that IL-8 and MMP-9 are the
downstream genes of MTDH.
Discussion
Cancer-related inflammation is an important hallmark of cancer
[28,29]. Inflammation induces the genetic instability in the tumor
microenvironment [30]. Two pathways have been identified
linking inflammation and cancer: the extrinsic ones and intrinsic
ones [31]. In the extrinsic pathway, inflammatory environment
promotes the malignancy of cancer. For example, the Helicobac-
ter pylori infection increases the risk of gastric cancer and hepatitis
virus infection is found in majority of liver cancers. Here, our study
provided the evidence that LPS could upregulate the expression of
MTDH which increases the invasiveness of breast cancer. In the
intrinsic pathway, genetic changes lead to the expression of
inflammation-related programs that guide the construction of an
inflammatory microenvironment. The production of cytokines
such as IL-8 and MMP-9 was increased, which could further help
inducing angiogenesis and modifying the extracellular matrix in
the tumor microenvironment. In our present study, we found that
MTDH is a molecule linking inflammation and cancer.
Toll-like receptors (TLRs) are a family of pattern recognition
receptors that are best-known for their role in initiation of the
innate and adaptive immune responses. However, recent evidenc-
es showed that functional TLRs are also expressed in a wide
variety of tumors suggesting that TLRs may play important roles
in tumor biology. An earlier report revealed that TLR4 was
expressed on many tumor cell surfaces and associated with the risk
of prostate cancer, nasopharyngeal carcinoma and gastric
carcinoma [22]. LPS, the ligand of TLR4, was reported to
increase the lung metastasis in 4T1 mouse mammary carcinoma
cells [32]. Furthermore, a recent study showed that samples of
breast carcinomas with recurrence exhibit a significant increase in
the mRNA levels of TLR4 and that TLR4 expression is
significantly associated with a great rate of distant metastasis
[33]. Also the activation of NF-kB, which is the downstream gene
of TLR4, contributed to mammary epithelial tumor progression in
Figure 3. The in vitro scratch assays show increased migration ability in LPS-treated MDA-MB-231 cells. (A) Relative MTDH mRNA levels
and protein levels in MDA-MB-231 cells transfected with prp-control or prp-MTDH vector respectively were measured by Real Time RT-PCR and
western blot, respectively. (B) Images of un-pretreated or 100 ng/ml LPS-pretreated prp-control and prp-MTDH transfected MDA-MB-231 cells were
taken at 0 and 24 hours. Images are shown at the original magnification of6100. (C) Cell motility was quantified by measuring the distance between
the migrating cell boundaries. Data were presented as mean6SD, n=5. Significant difference on wound distance was observed between prp-control-
MDA-MB-231 (prp-control) and prp-MTDH-MDA-MB-231 (prp-MTDH) cells, LPS-pretreated and un-pretreated prp-control cells, LPS-pretreated prp-
control and prp-MTDH MDA-MB-231 cells. No significant differences was observed between LPS-pretreated and un-pretreated T47D and prp-MTDH-
231 cells. T-test was carried out to examine the differences, *:p,0.05 was considered significant compared with the LPS untreated cells.
doi:10.1371/journal.pone.0029363.g003
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decreased numbers of lung metastases [34]. All these results
provide a possibility that TLR4- NF-kB pathway is a connection
between inflammation, immunity and cancer.
In our study, TLR4 expressed in breast cancer cell line MDA-
MB-231, MCF-7 and MDA-MB-468. We demonstrated the
activation of NF-kB with the stimulation of LPS in accordance
with the overexpression of MTDH. Previously, MTDH was
reported as a LPS-responded gene in proinflammatory cells which
suggested that MDTH may play an important role in the
regulation of innate immunity [11]. Moreover, MDTH is also
involved in tumor progression, migration and invasion as a NF-kB
dependent gene in Hela cells [24,27]. It functioned as a bridging
molecule between NF-kB, CBP (cyclic AMP-responsive element
binding protein-binding protein) and the basal transcription
machinery. The present study demonstrated for the first time that
LPS could increase the MTDH expression via activating the
TLR4-NF-kB signaling pathway in human breast cancer cells, we
hypothesized that there might be a positive feedback loop that LPS
stimulation initiated a signaling cascade leading to upregulated
expression of MTDH, which subsequently activated NF-kB,
resulting in a second phase of TLR4 activation or TRIF
activation, reinforcing and amplifying LPS-induced signaling.
Our results provided evidence that MTDH correlated the
inflammation, innate immunity and carcinogenesis together.
It has been reported that the LPS-induced metastatic growth
was associated with increased angiogenesis vascular permeability
and tumor cell invasion [35]. In this study we have shown the
Figure 4. Knockdown of MTDH abolishes LPS-induced breast cancer cell invasion. (A) Images were taken from invasion assays using
transwell system with or without the stimulation of LPS (100 ng/ml) for 18 hours in T47D, prp-control and prp-MTDH MDA-MB-231 cells. Images are
shown at the original magnification of 6100. (B) The number of successfully invaded cells. The cell numbers were counted at five representative
fields. Data was presented as mean6SD. The invaded cell number difference between T47D cells without LPS stimulation (22.662.1) and with LPS
stimulation (25.261.9) was not significant (p=0.074). The invaded cell number difference between prp-control MDA-MB-231 cells (92.268.6) and LPS-
treated prp-control MDA-MB-231 cells (129.8612.6) was significant; so was that between prp-control and prp-MTDH MDA-MB-231 cells with or
without LPS stimulation, *:p,0.05 was considered significant compared with the LPS untreated cells.
doi:10.1371/journal.pone.0029363.g004
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believed to function as a chemoattractant and a potent angiogenic
factor. Furthermore, IL-8 can promote cell invasion and
migration, and the capacity of IL-8 to induce tumor-associated
macrophages to secrete additional growth factors will further
increase the rate of cell proliferation and cancer cell invasion at the
tumor site[36]. MMP-9, a 92 kDa type IV collagenase, 92 kDa
gelatinase or gelatinase B (GELB), is a key effecter of ECM
remodeling. MMP-9 is activated to degrade type IV and V
collagens and promote the process of metastasis. In the present
study, LPS upregulated the MTDH expression and further
activated the NF-kB pathway, promoting the secretion of the
downstream genes such as IL-8 and MMP-9 in prp-control-231
cells. With the knockdown of MTDH, the induction of the mRNA
expression of IL-8 and MMP-9 decreased profoundly, and LPS
treatment did not increase their secretion. This indicated that
MTDH increased the metastatic ability of breast cancer via the
secretion of these cytokines. Besides, there was study put forward
the hypothesis that signaling through TLR4 is strongly inhibited
by intact extracellular matrix and that inhibition is abrogated and
endogenous agonist(s) are liberated when the matrix is degraded
[37]. It is possible that with upregulation of MTDH induced by
LPS, the secretion of cytokines such as MMPs increased greatly
and could degrade the extracellular matrix which then further
activated the TLR4 and enhanced the invasive ability of cancer
cells.
In summary, induction of MTDH by LPS could increase the
migration and invasiveness in the TLR4 positive breast cancer
cells. To date, we are the first to show the role of MTDH in the
TLR4 signaling pathway in breast cancer cell line, MDA-MB-231
cells. The results provide evidence that MTDH might be a pivotal
molecule not only in the progression of cancers but also in relation
of cancer, innate immunity and inflammation. However, the
immune evasion possibly mediated by TLR4- NF-kB-MTDH
pathway should be further studied. The relationship between
MTDH and TLR4 signaling pathway might lead to the




LPS isolated from Escherichia coli (0111:b4) was purchased
from Sigma Chemical Co. (St. Louis, MO). The rabbit
polyclonal antibody to TLR4, clone H-80, was purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Primary
antibodies against MyD88, TRIF, IRAK4, NF-kBp 6 5a n d
phospho-NF-kB (P-p65) were purchased from Cell Signaling
Technology (Beverly, MA, USA). Dulbecco’s Modified Eagle’s
Medium (DMEM), RPMI Medium 1640 were purchased from
Gibco-BRL (Rockville, IN, USA). Fetal bovine serum (FBS) was
supplied by Haoyang Biological Manufacturer Co., Ltd
(Tianjin, China).
Cell culture
Breast cancer cell lines T47D, MDA-MB-231, MCF-7 and
MDA-MB-468 were obtained from American Type Culture
Collection (ATCC). Breast cancer cells T47D were cultured in
RPMI-1640 supplemented with 10% FBS and 0.2 U/ml insulin
while MDA-MB-231, MCF-7 and MDA-MB-468 were routinely
cultured in DMEM supplemented with 10% FBS and 100 units of
penicillin-streptomycin at 37uC with 5% CO2 in a humidified
incubator. For LPS treatment, LPS was added in the culture
medium for the indicated times and concentrations.
Figure 5. MTDH regulates LPS-induced NF-kB activation and cytokine production. (A) Protein expression levels were determined by
Western-blot assays. Protein extracts were prepared from the prp-control and prp-MTDH MDA-MB-231 cells treated without or with LPS (100 ng/
ml) for 1 hour. (B, C) The mRNA levels of IL-8 (B) and MMP-9 (C) were measured by Real Time RT-PCR. Total RNA was extracted from cells in with
or without of LPS (100 ng/ml) for 24 hours. b-actin was used as an endogenous control. Each experiment was carried out three times
independently.
doi:10.1371/journal.pone.0029363.g005
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Cells were washed three times with cold phosphate-buffer saline
(PBS) and lysed on ice in RIPA (16PBS, 1% NP40, 0.1% sodium
dodecyl sulfate (SDS), 5 mM EDTA, 0.5% sodium deoxycholate
and 1 mM sodium orthovanadate) with protease inhibitors. The
concentrations of protein were determined by BCA methods.
Eighty micrograms of protein were separated by 10% SDS-PAGE
and electro-blotted to a PVDF membrane using a semi-dry
blotting apparatus (Bio-Rad, Hercules, CA, USA). After blocked in
5% non-fat milk, the membranes were incubated overnight at 4uC
with the primary antibodies. Then membranes were incubated in
the secondary antibodies for 2 hours at room temperature with
slightly shock. The bands are visualized using a Pro-lighting HRP
agent. b-actin was used as a loading control.
Real-Time RT-PCR
Total RNA was extracted with TRIZOL reagents according to
the manufacturer’s protocol (invitrogen, Carlsbad, CA, USA). The
cDNA was synthesized from 800 ng of total RNA by PrimerScript
RT Reagent Kit (TaKaRa BIO Inc, Otsu, Shiga, Japan). The
real-time RT-PCR was carried out by using a SYBR green PCR
mix in Applied Biosystems StepOne and StepOnePlus Real-Time
PCR Systems. The gene expression values were calculated by
normalizing with endogenous control b-actin with DataAssist
software. Each experiment was repeated three times to confirm the
conclusions.
Plasmids construction and Cell transfection
The plasmids used in the experiment were described previously
(Hu, Chong et al. 2009). Briefly, two different short-hairpins RNA
(shRNA) were constructed to knockdown the expression of
MTDH in MDA-MB-231 cell line, generating the psuper-retro-
puro-MTDH (prp-MTDH) cells, psuper-retro-puro vector was
used as control (prp-control). Cells were seeded in six-well plates
24 hours before the transfection and were transfected with psuper-
retro-puro-MTDH or psuper-retro-puro vectors by Lipofectamine
2000 transfection reagent (Invitrogen, USA) according to the
manufacturer’s instructions. Cells were selected for 2 weeks in
0.5 ug/ml puromycin and maintained in 0.2 ug/ml puromycin.
The expression levels of MTDH in surviving colonies were
evaluated by western blot and RT-PCR.
In vitro scratch assays
The cells were seeded in 24-well plates at a density 1610
5 cells/
well. After incubation overnight, cells were stimulated with LPS
(100 ng/ml) for 4 hours, and then scraped by a p20 pipette tips to
create a straight-line cell-free scratch. Each well was washed with
PBS three times to remove the remaining unattached cells and
debris. The scratch area were marked and photographed in every
12 hours. The distances were measured by the software imageJ
and cell motility was quantified by measuring the distance between
the migrating cell boundaries [38]. Data were analyzed statisti-
cally.
Invasion assays
The transwell system (24 wells, 8 um pore size, BD Biosciences,
Heidelberg, Germany) coated with 2 mg/ml basement membrane
Matrigel (BD Biosciences) were used for the in vitro invasion
assays. 1610
5 cells were suspended in serum-free DMEM in the
upper chamber of each well. The lower well of each chamber was
filled with 750 ul DMEM supplemented with 20% FBS. LPS
(100 ng/ml) was added to both the upper and the lower chambers.
After 18 hours of LPS treatment, filters were fixed with methanol
and stained with 0.1% crystal violet. Then the number of cells in at
least five randomly selected microscope fields were counted and
analyzed statistically.
Statistical evaluation
Statistical differences were analyzed by Student’s t-test, p,0.05
was considered significant. Independent repeated experiments
were carried out at least three times.
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